A receptor fusion protein for the inhibition of murine oncostatin M
2011

Inhibiting Murine Oncostatin M with a Receptor Fusion Protein

publication Evidence: high

Author Information

Author(s): Liv Brolund, Andrea Küster, Sabrina Korr, Michael Vogt, Gerhard Müller-Newen

Primary Institution: RWTH Aachen University

Hypothesis

Can receptor fusion proteins effectively inhibit murine oncostatin M?

Conclusion

The mOSM-RFP is a highly potent and specific inhibitor of murine oncostatin M.

Supporting Evidence

  • The mOSM-RFP effectively blocks the activity of murine oncostatin M.
  • Inhibitory activity was confirmed through experiments with murine embryonic fibroblasts.
  • The receptor fusion proteins were shown to be specific inhibitors of mOSM.

Takeaway

Scientists created a special protein that can stop a harmful substance in mice that causes inflammation. This could help in treating diseases.

Methodology

The study involved constructing receptor fusion proteins and testing their inhibitory effects on murine embryonic fibroblasts.

Limitations

The study primarily focuses on murine models, which may not fully translate to human conditions.

Digital Object Identifier (DOI)

10.1186/1472-6750-11-3

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication